Position in ABSI
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$78,112,833
+$53,352,885 QoQ
Shares Held
6,739,675
-18.3% QoQ
Ownership
3.93%
of shares outstanding
% of Portfolio
5.24%
of 13F equity value
Holder Rank
#6
of 197 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABSI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Redmile Group, LLC holds $1,454,356,867 across 35 Biotechnology names. ABSI ranks #6 (5.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SRRK |
Scholar Rock Holding Corp
|
4,311,092 | $237,110,060 | |
| 2 | KRYS |
Krystal Biotech, Inc.
|
632,005 | $234,897,298 | |
| 3 | STOK |
Stoke Therapeutics, Inc.
|
3,945,920 | $129,110,502 | |
| 4 | IMNM |
Immunome Inc.
|
4,911,590 | $104,076,592 | |
| 5 | NRIX |
Nurix Therapeutics, Inc.
|
4,073,787 | $98,830,072 | |
| 6 | ABSI |
Absci Corp
This page
|
6,739,675 | $78,112,833 | |
| 7 | ANNX |
Annexon, Inc.
|
11,869,877 | $67,776,997 | |
| 8 | RGNX |
REGENXBIO Inc.
|
4,368,804 | $52,338,271 |
All Filings in ABSI
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $78,112,833 | 6,739,675 | Shares | Sole | 2026-08-14 | |
| 2026-04-10 | $22,670,198 | 7,607,449 | Shares | Sole | 2026-04-14 | |
| 2026-03-31 | $24,759,948 | 8,253,316 | Shares | Sole | 2026-05-15 | |
| 2026-03-24 | $24,842,481 | 8,253,316 | Shares | Sole | 2026-03-26 | |
| 2025-12-31 | $28,804,072 | 8,253,316 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $25,090,080 | 8,253,316 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $21,211,022 | 8,253,316 | Shares | Sole | 2025-08-14 | |
| 2025-04-25 | $26,088,913 | 8,335,116 | Shares | Sole | 2025-04-29 | |
| 2025-03-31 | $20,715,823 | 8,253,316 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $21,623,687 | 8,253,316 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $31,527,667 | 8,253,316 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $25,420,213 | 8,253,316 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $46,878,834 | 8,253,316 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $33,730,594 | 8,031,094 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $10,601,044 | 8,031,094 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $12,207,262 | 8,031,094 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $14,054,414 | 8,031,094 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $16,865,297 | 8,031,094 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $25,137,324 | 8,031,094 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $26,663,232 | 8,031,094 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $67,702,122 | 8,031,094 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $65,854,970 | 8,031,094 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $93,401,623 | 8,031,094 | Shares | Sole | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||